Skip to main content
. 2014 Apr 5;7:23. doi: 10.1186/1757-1146-7-23

Table 5.

Relevant outcome measures related to changes in: physical function (significant SMD results are bolded) – outcomes are measured during walking unless otherwise noted

Study Activity Outcome No FO (mean ± SD) Device FO (mean ± SD)
Rome and Brown [48]
Quiet standing
Mean of the 300 balance points measured over 30 seconds (%)
49.40*^
NA
46.10*^
Medial to lateral sway - rate of deviation from the mean balance over 30 seconds (%)
1.90*^
NA
1.30*^
Anterior to posterior sway - rate of deviation from the mean balance over 30 seconds (%)
4.60*^
NA
4.80*^
Otman et al. [50]
Walking on treadmill at 1.34 m/s
Energy cost (ml/kg/min)
13.90*
NA
12.76*
Murley et al. [40]
Over-ground walking (self-selected ± 5%)
TP EMG peak amplitude (initial contact and loading)%
101.91 (33.9)
A
89.51 (36.8)
B
82.48 (31.8)
TP EMG RMS amplitude (initial contact and loading)%
101.94 (30.9)
A
89.37 (33.6)
B
80.01 (25.7)
TP EMG peak amplitude (midstance, terminal and pre-swing) (% of gait cycle)
90.96 (28.8)
A
89.62 (22.2)
B
87.34 (27.3)
TP EMG RMS amplitude (midstance, terminal and pre-swing)%
89.60 (24.1)
A
86.92 (17.83)
B
85.84 (23.9)
PL EMG peak amplitude (initial contact and loading)%
80.16 (35.6)
A
84.70 (42.1)
B
90.48 (47.3)
PL EMG RMS amplitude (initial contact and loading)%
79.44 (27.6)
A
84.25 (37.5)
B
98.10 (44.6)
PL EMG peak amplitude (midstance, terminal and pre-swing) (% of gait cycle)
62.71 (32.6)
A
67.78 (33.9)
B
83.76 (41.9)
PL EMG RMS amplitude (midstance, terminal and pre-swing)%
71.90 (39.9)
A
79.86 (46.0)
B
96.07 (47.9)
TA EMG peak amplitude (initial contact and loading)%
116.32 (15.8)
A
113.49 (15.3)
B
111.50 (17.4)
TA EMG RMS amplitude (initial contact and loading)%
122.02 (19.8)
A
119.79 (22.0)
B
113.00 (22.3)
TP EMG time of peak amplitude (initial contact and loading) (% of gait cycle)
10.94 (1.7)
A
11.37 (2.1)
B
11.10 (2.2)
TP EMG time of peak amplitude (midstance, terminal and pre-swing) (% of gait cycle)
44.95 (4.3)
A
44.92 (3.69)
B
45.55 (4.1)
PL EMG time of peak amplitude (initial contact and loading) (% of gait cycle)
10.65 (3.4)
A
10.52 (3.5)
B
10.23 (4.6)
PL EMG time of peak amplitude (midstance, terminal and pre-swing) (% of gait cycle)
51.65 (7.0)
A
50.55 (7.91)
B
50.26 (7.61)
TA EMG time of peak amplitude (initial contact and loading) (% of gait cycle)
6.63 (1.4)
A
6.28 (1.3)
B
6.39 (1.4)
Zammit and Payne [42]
FHSQ reported at baseline and 4 weeks
Increase in FHSQ function subscale (increase in function)
64.94 (24.0)*
NA
85.32 (17.7)*
Murley and Bird [40]
Over-ground walking (self-selected speed)
PL EMG amplitude (% MVIC)
88.00 (26.5)
A
98.00 (32.9)
B
107.00 (35.8)
C
99.00 (32.6)
TA EMG amplitude (% MVIC)
122.00 (38.4)
A
123.00 (42.2)
B
129.00 (43.1)
C
125.00 (30.0)
Soleus EMG amplitude (% MVIC)
256.60 (89.6)
A
251.93 (95.7)
B
255.70 (94.5)
C
260.92 (98.4)
Chen et al. [39] Over-ground walking (1.09 ± 0.11 m/s) Velocity (cm/s)
108.57 (11.3)
NA
109.39 (11.1)
Cadence (steps/min)
103.98 (6.8)
NA
104.73 (5.8)
Step width(cm)
15.44 (5.2)
NA
15.44 (5.0)
Step length(cm)
63.09 (4.9)
NA
61.81 (4.4)
Stance time (%) 63.72 (1.7) NA 63.93 (1.9)

FO – foot orthoses, EMG – electromyography, TP – tibialis posterior, PL – peroneus longus, TA – tibialis anterior, RMS – root mean square, MVIC – maximum voluntary isometric contraction, FHSQ – foot health status questionnaire, NA – not applicable, N/A – not available, *No FO condition was prior to orthoses dispense, the FO condition was following four weeks of orthoses use, ^ Median results and significance tabled as per original article– means and standard deviations unavailable.